Expert guidance, practical advice, and strategic insights for international companies entering the U.S. market.
Filter by topic
Houston just topped GEN's first ranking of emerging U.S. biopharma clusters. It has been one for decades. Learn what the Texas Medical Center offers international life sciences companies, what Boston still does better, and who Houston is right for.
Read more
AI is making production cheap. Learn why judgment, prioritization, taste, and deliberate non-production are becoming the scarce leadership capabilities that matter most.
Read more
AI can help international companies entering the U.S., but only when it supports the right operational priorities instead of distracting from market validation.
Read more
A practical guide to using AI tools without exposing customer data, source code, contracts, or other sensitive company information.
Read more
AI adoption is no longer just a question of whether to start. Learn why the operational gap between SMB adopters and non-adopters is widening quickly.
Read more
Most SMBs are not behind on AI because they have not tried it. They are behind because they started with tools instead of the foundation that makes AI useful.
Read moreFollow our company page on LinkedIn for the latest insights, market updates, and practical guidance.
Follow Us on LinkedIn